mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |